The Psychiatric Mental Health Advanced Practice Registered Nurse Workforce: Charting the Future

Journal of the American Psychiatric Nurses Association
Kathleen Delaney, Dawn Vanderhoef

Abstract

To characterize the future Psychiatric Mental Health (PMH) Advanced Practice Registered Nurse (APRN) workforce in light of the high demand for psychiatric providers in all aspects of mental health service delivery. Over the past 20 years, there has been significant growth of the PMH APRN workforce, a provider group capable of addressing mental health provider shortages. However, continued growth may be limited by anticipated retirements and traditional volume of graduations from PMH nurse practitioner (NP) programs. Optimum utilization of PMH APRNs in service delivery systems and State workforce planning may also be impeded by their frequent mischaracterized in federal reports and mental health workforce studies. Based on a review of the literature, this discussion paper evaluates trends related to PMH NP programs and graduates, anticipated retirements of current PMH ARPNs, facilitators and barriers to increasing the PMH APRN workforce, and opportunities and threats to workforce development. The PMH APRN workforce faces significant challenges owing to barriers and facilitators to growth of the specialty. These factors conspire to limit the supply of PMH APRNs at a time when they are needed to compensate for declining numbers of...Continue Reading

References

Jan 22, 2008·Archives of Psychiatric Nursing·Margaret J Halter
Jul 3, 2013·BMC Health Services Research·Bridget Teevan BurkeRobert L Phillips
Sep 30, 2014·Journal of the American Association of Nurse Practitioners·Ingrid ForsbergKathleen R Delaney
Nov 15, 2014·Issues in Mental Health Nursing·Lauren HunterBarbara A Harris
Dec 30, 2015·Journal of the American Psychiatric Nurses Association·Lois K EvansCornelia Beck
Nov 3, 2016·Journal of Psychosocial Nursing and Mental Health Services·Janet YorkCarole Hair
Jan 12, 2017·Journal of the American Psychiatric Nurses Association·Dawn M Vanderhoef, Kathleen R Delaney
May 16, 2017·Psychiatric Services : a Journal of the American Psychiatric Association·Kathleen R Delaney
Jun 6, 2017·Nursing Outlook·Di Fang, Karen Kesten
Jun 16, 2017·Psychiatric Services : a Journal of the American Psychiatric Association·Bo Kyum YangShannon Idzik
May 22, 2018·American Journal of Preventive Medicine·Susan A ChapmanDeborah C Strod
Jun 5, 2018·Journal of the American Psychiatric Nurses Association·Kathleen R DelaneyAmy Rushton
Jul 22, 2018·Archives of Psychiatric Nursing·Emily B Jones
Mar 25, 2019·Journal of Professional Nursing : Official Journal of the American Association of Colleges of Nursing·Kathleen R Delaney, Niranjan S Karnik

❮ Previous
Next ❯

Citations

Sep 6, 2019·Journal of Advanced Nursing·Hao-Yuan ChangChing-I Teng
Oct 8, 2019·Journal of the American Psychiatric Nurses Association·Merrie J Kaas
Oct 21, 2020·Psychiatric Services : a Journal of the American Psychiatric Association·Katharine M Frissora, Jules M Ranz
Dec 2, 2020·Clinical Nurse Specialist CNS·Elizabeth Ann Scruth
Oct 10, 2020·Archives of Psychiatric Nursing·Matthew TierneyElizabeth M Pace
Oct 10, 2020·Archives of Psychiatric Nursing·Robbi K AlexanderJennifer S Graber
Apr 7, 2021·Perspectives in Psychiatric Care·Ozge SukutEsra Albal
Jan 3, 2021·Nursing Outlook·Catherine Crawford CohenHeather L Tubbs-Cooley
Jun 19, 2021·Journal of Psychosocial Nursing and Mental Health Services·Karan S Kverno, Ashley Fenton
Jul 1, 2021·Journal of Professional Nursing : Official Journal of the American Association of Colleges of Nursing·Priscilla Margaret NodineShane Hoon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.